Alex Sverdlov BSc, MSc, PhD

Alex Sverdlov has worked as a statistical scientist in biopharmaceutical industry since 2007, in such companies as Novartis, Merck Serono and Bristol-Myers Squibb. He handled clinical trials in neurodegenerative diseases, metabolic disorders, ophthalmology, immunology, and oncology. Alex has been involved in active research on adaptive designs for clinical trials to improve efficiency of drug development. He edited a book “Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects” which was published by CRC Press in 2015. Alex’s most recent work involves design of proof-of-endpoint clinical trials evaluating digital technology (including wearable devices) in neuroscience.